Literature DB >> 31223437

Closing the Loop: Developing an Integrated Design, Make, and Test Platform for Discovery.

David M Parry1.   

Abstract

The relatively slow cycle time within medicinal chemistry from synthesis to assay is constantly being challenged to help improve the efficiency of the discovery process. While both synthesis and assay have been automated to varying degrees, there has, until recently, been limited focus on the complete design, make, and test process. This Innovations article outlines the development of Cyclofluidic from inception through to the commercialization of a fully integrated closed loop design, synthesis, and screen platform.

Entities:  

Year:  2019        PMID: 31223437      PMCID: PMC6580368          DOI: 10.1021/acsmedchemlett.9b00095

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  17 in total

1.  The medicinal chemist's toolbox for late stage functionalization of drug-like molecules.

Authors:  Tim Cernak; Kevin D Dykstra; Sriram Tyagarajan; Petr Vachal; Shane W Krska
Journal:  Chem Soc Rev       Date:  2015-10-28       Impact factor: 54.564

Review 2.  Microreactors as new tools for drug discovery and development.

Authors:  S Y F Wong-Hawkes; J C Matteo; B H Warrington; J D White
Journal:  Ernst Schering Found Symp Proc       Date:  2006

3.  Chromatographic Hydrophobicity Index by Fast-Gradient RP-HPLC:  A High-Throughput Alternative to log P/log D.

Authors:  K Valkó; C Bevan; D Reynolds
Journal:  Anal Chem       Date:  1997-06-01       Impact factor: 6.986

4.  Organic synthesis: march of the machines.

Authors:  Steven V Ley; Daniel E Fitzpatrick; Richard J Ingham; Rebecca M Myers
Journal:  Angew Chem Int Ed Engl       Date:  2015-01-13       Impact factor: 15.336

5.  Integrated Platform for Expedited Synthesis-Purification-Testing of Small Molecule Libraries.

Authors:  Aleksandra Baranczak; Noah P Tu; Jasmina Marjanovic; Philip A Searle; Anil Vasudevan; Stevan W Djuric
Journal:  ACS Med Chem Lett       Date:  2017-03-28       Impact factor: 4.345

6.  Continuous-flow injection microfluidic thrombin assays: The effect of binding kinetics on observed enzyme inhibition.

Authors:  Manoj K Ramjee; Sital Patel
Journal:  Anal Biochem       Date:  2017-04-27       Impact factor: 3.365

7.  Rapid discovery of a novel series of Abl kinase inhibitors by application of an integrated microfluidic synthesis and screening platform.

Authors:  Bimbisar Desai; Karen Dixon; Elizabeth Farrant; Qixing Feng; Karl R Gibson; Willem P van Hoorn; James Mills; Trevor Morgan; David M Parry; Manoj K Ramjee; Christopher N Selway; Gary J Tarver; Gavin Whitlock; Adrian G Wright
Journal:  J Med Chem       Date:  2013-03-25       Impact factor: 7.446

8.  Seamless integration of dose-response screening and flow chemistry: efficient generation of structure-activity relationship data of β-secretase (BACE1) inhibitors.

Authors:  Michael Werner; Christoph Kuratli; Rainer E Martin; Remo Hochstrasser; David Wechsler; Thilo Enderle; Alexander I Alanine; Horst Vogel
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-23       Impact factor: 15.336

9.  Automated Lead Optimization of MMP-12 Inhibitors Using a Genetic Algorithm.

Authors:  Stephen D Pickett; Darren V S Green; David L Hunt; David A Pardoe; Ian Hughes
Journal:  ACS Med Chem Lett       Date:  2010-10-20       Impact factor: 4.345

10.  Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery.

Authors:  Werngard Czechtizky; Jüergen Dedio; Bimbisar Desai; Karen Dixon; Elizabeth Farrant; Qixing Feng; Trevor Morgan; David M Parry; Manoj K Ramjee; Christopher N Selway; Thorsten Schmidt; Gary J Tarver; Adrian G Wright
Journal:  ACS Med Chem Lett       Date:  2013-06-10       Impact factor: 4.345

View more
  8 in total

1.  Innovations Update.

Authors:  Stevan W Djuric
Journal:  ACS Med Chem Lett       Date:  2019-06-13       Impact factor: 4.345

2.  Selective Phenylimidazole-Based Inhibitors of the Mycobacterium tuberculosis Proteasome.

Authors:  Wenhu Zhan; Hao-Chi Hsu; Trevor Morgan; Tierra Ouellette; Kristin Burns-Huang; Ryoma Hara; Adrian G Wright; Toshihiro Imaeda; Rei Okamoto; Kenjiro Sato; Mayako Michino; Manoj Ramjee; Kazuyoshi Aso; Peter T Meinke; Michael Foley; Carl F Nathan; Huilin Li; Gang Lin
Journal:  J Med Chem       Date:  2019-10-15       Impact factor: 7.446

Review 3.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

4.  Synthesis of HDAC Inhibitor Libraries via Microscale Workflow.

Authors:  Kevin D Dykstra; Eric Streckfuss; Min Liu; Jian Liu; Younong Yu; Ming Wang; Joseph A Kozlowski; Robert W Myers; Alexei V Buevich; Milana M Maletic; Petr Vachal; Shane W Krska
Journal:  ACS Med Chem Lett       Date:  2021-02-08       Impact factor: 4.345

5.  A Dynamic Hanging-Drop System for Mesenchymal Stem Cell Culture.

Authors:  Shu-Wei Huang; Shian-Chiuan Tzeng; Jem-Kun Chen; Jui-Sheng Sun; Feng-Huei Lin
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 6.  Defining Levels of Automated Chemical Design.

Authors:  Brian Goldman; Steven Kearnes; Trevor Kramer; Patrick Riley; W Patrick Walters
Journal:  J Med Chem       Date:  2022-05-05       Impact factor: 8.039

Review 7.  Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer.

Authors:  Yu Cao; Huajian Zhu; Ruoyu He; Limin Kong; Jiaan Shao; Rangxiao Zhuang; Jianjun Xi; Jiankang Zhang
Journal:  Drug Des Devel Ther       Date:  2020-10-19       Impact factor: 4.162

8.  Current and Future Roles of Artificial Intelligence in Medicinal Chemistry Synthesis.

Authors:  Thomas J Struble; Juan C Alvarez; Scott P Brown; Milan Chytil; Justin Cisar; Renee L DesJarlais; Ola Engkvist; Scott A Frank; Daniel R Greve; Daniel J Griffin; Xinjun Hou; Jeffrey W Johannes; Constantine Kreatsoulas; Brian Lahue; Miriam Mathea; Georg Mogk; Christos A Nicolaou; Andrew D Palmer; Daniel J Price; Richard I Robinson; Sebastian Salentin; Li Xing; Tommi Jaakkola; William H Green; Regina Barzilay; Connor W Coley; Klavs F Jensen
Journal:  J Med Chem       Date:  2020-04-14       Impact factor: 7.446

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.